Early response to highly active antiretroviral therapy in HIV-1-infected Kenyan children.

Citation:
Wamalwa DC, Farquhar C, Obimbo EM, Selig S, Mbori-Ngacha DA, Richardson BA, Overbaugh J, Emery S, Wariua G, Christine Gichuhi, Dalton Wamalwa, Bosire R, John-Stewart G. "Early response to highly active antiretroviral therapy in HIV-1-infected Kenyan children." J. Acquir. Immune Defic. Syndr.. 2007;45(3):311-7.

Abstract:

To describe the early response to World Health Organization (WHO)-recommended nonnucleoside reverse transcriptase inhibitor (NNRTI)-based first-line highly active antiretroviral therapy (HAART) in HIV-1-infected Kenyan children unexposed to nevirapine.

UoN Websites Search